1. Home
  2. JWEL vs GOVX Comparison

JWEL vs GOVX Comparison

Compare JWEL & GOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jowell Global Ltd.

JWEL

Jowell Global Ltd.

HOLD

Current Price

$2.13

Market Cap

5.1M

ML Signal

HOLD

Logo GeoVax Labs Inc.

GOVX

GeoVax Labs Inc.

HOLD

Current Price

$2.77

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JWEL
GOVX
Founded
2012
2001
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
JWEL
GOVX
Price
$2.13
$2.77
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$103.00
AVG Volume (30 Days)
31.1K
194.5K
Earning Date
05-12-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$123,450,865.00
$3,353,560.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
8.52
52 Week Low
$1.47
$2.61
52 Week High
$3.24
$53.73

Technical Indicators

Market Signals
Indicator
JWEL
GOVX
Relative Strength Index (RSI) 43.40 66.94
Support Level $2.06 $2.72
Resistance Level $2.23 $3.42
Average True Range (ATR) 0.11 0.39
MACD -0.00 0.08
Stochastic Oscillator 28.21 61.95

Price Performance

Historical Comparison
JWEL
GOVX

About JWEL Jowell Global Ltd.

Jowell Global Ltd is a cosmetics, health, nutritional supplements, and household products e-commerce platform in China. The company offers its branded products to customers and also sells and distributes products from other companies on its platform. In addition, it allows third parties to open their stores on its platform for a service fee based on their sales revenues generated from their online stores and provides them with information about market needs, enabling them to manage their sales effort, as well as an effective platform to promote their brands. The company currently operates under four sales channels: Online Direct Sales, Authorized Retail Store Distribution, Third-party Merchants, and Live streaming marketing. Geographically, it generates all of its revenue from the PRC.

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors. The Company's key clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine.

Share on Social Networks: